Moderna Q2 Earnings Call Highlights
Reported by Yahoo Finance · finance.yahoo.com · July 31, 2026
Moderna (NASDAQ:MRNA) reported second-quarter revenue of $145 million, exceeding the high end of its prior guidance range, while continuing to reduce costs and advance programs spanning respiratory vaccines, oncology and rare diseases. The company posted a net loss of $782 million, or $1.97 per sha
What the tape says
What to watch: This report cites a concrete figure ($145 million) — compare it against the trailing trend before treating one data point as a turning point.
Market reaction today: $MRNA -4.30%
Tone and severity are deterministic keyword classification — not a prediction, a member vote, or a recommendation. Figures are extracted from the headline as published. Wook does not republish Yahoo Finance's reporting.
Your read
Discussion
No one has weighed in yet. Start the discussion on this story.
Headline and link are attributed to Yahoo Finance. Wook of Wall Street is an independent research tool and is not affiliated with Yahoo Finance. Nothing here is financial advice or a recommendation — research and educational content only.